Tharimmune, Inc. Files 2024 Annual Report

Ticker: CNTN · Form: 10-K · Filed: Mar 26, 2025 · CIK: 1861657

Tharimmune, INC. 10-K Filing Summary
FieldDetail
CompanyTharimmune, INC. (CNTN)
Form Type10-K
Filed DateMar 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Tharimmune (fka Hillstream BioPharma) dropped its 2024 10-K. All eyes on their pharma prep biz.

AI Summary

Tharimmune, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 26, 2025. The company, formerly known as Hillstream BioPharma Inc. until September 25, 2023, is focused on pharmaceutical preparations. The filing details financial information and business operations for the period.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Tharimmune's financial health and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Tharimmune faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is Tharimmune, Inc.'s primary business activity?

Tharimmune, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.

When did Tharimmune, Inc. change its name?

Tharimmune, Inc. changed its name from Hillstream BioPharma Inc. on September 25, 2023.

What is the fiscal year end for this 10-K filing?

The fiscal year end for this 10-K filing is December 31, 2024.

What is the SEC file number for Tharimmune, Inc.?

The SEC file number for Tharimmune, Inc. is 001-41210.

Where is Tharimmune, Inc. located?

Tharimmune, Inc. has its business address at 1200 Route 22 East, Bridgewater, NJ 08807.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 26, 2025 regarding Tharimmune, Inc. (CNTN).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing